SMYD3 promoter hypomethylation is associated with the risk of colorectal cancer

CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population

(2017) Bin Li et al.   IMMUNOLOGY LETTERS

Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma

(2017) Xiao Fei et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer

(2017) Haochang Hu et al.   Oncotarget

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature

(2017) Michail Galanopoulos et al.   World Journal of Gastrointestinal Oncology

ATM Signaling Pathway Is Implicated in the SMYD3-mediated Proliferation and Migration of Gastric Cancer Cells

(2017) Lei Wang et al.   Journal of Gastric Cancer

SMYD3 Promotes Homologous Recombination via Regulation of H3K4-mediated Gene Expression

(2017) Yun-Ju Chen et al.   Scientific Reports

Elevated UMOD methylation level in peripheral blood is associated with gout risk

(2017) Yong Yang et al.   Scientific Reports

Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development

(2016) Michalis E. Sarris et al.   CANCER CELL

DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation

(2016) K. L. Sheaffer et al.   Cancer Prevention Research

DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study

(2016) Catherine L. Callahan et al.   Epigenetics

SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma

(2016) Ying Zhu et al.   HUMAN PATHOLOGY

Aging and DNA methylation

(2015) Marc Jung et al.   BMC BIOLOGY

A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth

(2015) Alessia Peserico et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Identification of functionally methylated regions based on discriminant analysis through integrating methylation and gene expression data

(2015) Yuanyuan Zhang et al.   Molecular BioSystems

SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity

(2015) BIN DAI et al.   ONCOLOGY REPORTS

Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer

(2015) YU-ZHOU QIN et al.   ONCOLOGY REPORTS

SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3

(2015) Filipa Quintela Vieira et al.   Oncotarget

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis

(2014) Y. Y. Juo et al.   ANNALS OF ONCOLOGY

Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms

(2013) Hermann Brenner   ANNALS OF INTERNAL MEDICINE

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer

(2013) R Bertorelle et al.   BRITISH JOURNAL OF CANCER

Deregulated expression of selected histone methylases and demethylases in prostate carcinoma

(2013) Filipa Quintela Vieira et al.   ENDOCRINE-RELATED CANCER

SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription

(2013) Cheng Liu et al.   JNCI-Journal of the National Cancer Institute

Colorectal Cancer: Molecular Mutations and Polymorphisms

(2013) Aga Syed Sameer   Frontiers in Oncology

Epigenetics of Colorectal Cancer

(2012) Ajay Goel et al.   GASTROENTEROLOGY

Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors

(2012) Annika Jögi et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells

(2011) N. Guo et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation

(2011) Fabio Coppedè   CANCER LETTERS

Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer

(2011) Lucia Migliore et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Epigenetics and colorectal cancer

(2011) Victoria Valinluck Lao et al.   Nature Reviews Gastroenterology & Hepatology

Structural and biochemical studies of human lysine methyltransferase Smyd3 reveal the important functional roles of its post-SET and TPR domains and the regulation of its activity by DNA binding

(2011) Shutong Xu et al.   NUCLEIC ACIDS RESEARCH

Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3

(2011) Kenneth W. Foreman et al.   PLoS One

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Diet and epigenetics in colon cancer

(2009) Minna Nyström et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking

(2008) Haijian Wang et al.   CANCER SCIENCE